Innoviva, Inc. (INVA)
18.93
+0.07
(+0.37%)
USD |
NASDAQ |
Nov 12, 15:45
Innoviva Price : 18.93 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 18.97 | 19.03 | 18.66 | 18.86 | 650128.0 |
| Nov 10, 2026 | 18.90 | 20.10 | 18.79 | 19.08 | 786121.0 |
| Nov 09, 2026 | 19.36 | 20.00 | 18.70 | 19.00 | 1.662M |
| Nov 06, 2026 | 19.54 | 19.87 | 19.02 | 19.10 | 1.654M |
| Nov 05, 2026 | 20.59 | 20.91 | 19.19 | 19.24 | 2.650M |
| Nov 04, 2026 | 21.28 | 21.52 | 21.03 | 21.26 | 922346.0 |
| Nov 03, 2026 | 21.07 | 21.40 | 20.90 | 20.93 | 712646.0 |
| Nov 02, 2026 | 21.25 | 21.62 | 20.89 | 21.02 | 1.121M |
| Oct 30, 2026 | 21.48 | 21.65 | 21.13 | 21.22 | 623267.0 |
| Oct 29, 2026 | 21.41 | 21.52 | 21.12 | 21.31 | 626929.0 |
| Oct 28, 2026 | 20.85 | 21.15 | 20.74 | 21.12 | 585273.0 |
| Oct 27, 2026 | 20.97 | 21.06 | 20.75 | 20.94 | 584440.0 |
| Oct 26, 2026 | 20.77 | 21.22 | 20.77 | 21.05 | 569096.0 |
| Oct 23, 2026 | 20.88 | 20.94 | 20.51 | 20.66 | 978553.0 |
| Oct 22, 2026 | 21.05 | 21.27 | 20.92 | 21.06 | 452078.0 |
| Oct 21, 2026 | 21.20 | 21.36 | 20.89 | 20.91 | 442222.0 |
| Oct 20, 2026 | 21.31 | 21.49 | 21.12 | 21.28 | 507564.0 |
| Oct 19, 2026 | 20.68 | 21.15 | 20.68 | 21.08 | 590514.0 |
| Oct 16, 2026 | 20.97 | 20.97 | 20.56 | 20.78 | 550486.0 |
| Oct 15, 2026 | 21.33 | 21.76 | 20.83 | 20.86 | 672982.0 |
| Oct 14, 2026 | 20.79 | 21.18 | 20.73 | 20.97 | 673510.0 |
| Oct 13, 2026 | 21.55 | 21.55 | 20.70 | 20.74 | 811565.0 |
| Oct 12, 2026 | 21.27 | 21.48 | 21.12 | 21.45 | 521194.0 |
| Oct 09, 2026 | 20.80 | 21.28 | 20.78 | 21.21 | 507581.0 |
| Oct 08, 2026 | 21.05 | 21.05 | 20.73 | 20.87 | 612353.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1435.38 |
| Merck & Co., Inc. | 147.44 |
| Pfizer Inc. | 28.95 |
| ANI Pharmaceuticals, Inc. | 71.29 |
| Corcept Therapeutics, Inc. | 73.82 |
Price Related Metrics
| PE Ratio | 9.474 |
| PS Ratio | 3.304 |
| PEG Ratio | 0.2186 |
| Price to Book Value | 1.191 |
| Price to Free Cash Flow | 8.184 |
| Earnings Yield | 10.56% |
| Market Cap | 1.354B |
| PEGY Ratio | 0.2186 |
| Operating PE Ratio | 8.778 |
| Normalized PE Ratio | 9.246 |